NCT00308971View on ClinicalTrials.gov

Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Chronic Kidney Disease
Interventions
DRUG

Alpha, gamma, beta, and delta (mixed) tocopherols

approximately 666 IU daily (1 pill) for 4 months

DRUG

alpha lipoic acid

600 mg daily (2 pills 300 mg each) for 4 months

DRUG

placebo

placebo for alpha, gamma, beta, and delta (mixed) tocopherols; 1 pill daily for 4 months

DRUG

placebo

placebo for alpha lipoic acid; 2 pills daily for 4 months

Trial Locations (2)

37232

Vanderbilt University Medical Center, Nashville

04102

Maine Medical Center, Portland

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00308971 - Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT) | Biotech Hunter | Biotech Hunter